LC-MS (/MS) in Clinical Toxicology Screening Methods

被引:10
|
作者
Viette, Veronique [3 ]
Hochstrasser, Denis [1 ,2 ,4 ]
Fathi, Marc [1 ,4 ]
机构
[1] Univ Hosp Geneva, Toxicol Lab, Div Lab Med, Dept Genet & Lab Med, CH-1211 Geneva 14, Switzerland
[2] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland
[3] ADMed Labs, CH-2300 La Chaux De Fonds, Switzerland
[4] Univ Geneva, CMU, Swiss Ctr Appl Human Toxicol, CH-1206 Geneva, Switzerland
关键词
Clinical toxicology; Identification; LC/MS; Screening; CHROMATOGRAPHY-MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; ION-TRAP; DRUGS; URINE; LIBRARY; MS/MS; BLOOD; IDENTIFICATION; GUIDELINES;
D O I
10.2533/chimia.2012.339
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Toxicological screening is the analysis of biological samples to detect and identify unknown compounds. The high selectivity and sensitivity of liquid chromatography (LC) coupled to mass spectrometry (MS) or tandem mass spectrometry (MS/MS) technology provide an attractive alternative to the current methods (LC-UV, GC/MS, etc.). For these reasons, an increasing number of applications are being published. This paper is a brief overview of LC-MS(/MS) screening methods developed for clinical toxicology in recent years. Various sample treatments, chromatographic separations and detection by mass spectrometry can be combined to obtain screening methods adapted to the constraints and needs of clinical toxicology laboratories. Currently the techniques are in the hands of specialists, mainly in academic institutions. However, the evolution in technology should allow application of these techniques as a tool in toxicology laboratories, thus allowing a more widespread exploitation of their potential.
引用
收藏
页码:339 / 342
页数:4
相关论文
共 50 条
  • [1] LC/MS/MS screening in clinical toxicology
    Fathi, M.
    Viette, V.
    Karmime, A.
    Hughes, S.
    Binz, P. A.
    Mylonas, R.
    Masselot, A.
    Budin, N.
    Hochstrasser, D.
    [J]. THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 487 - 487
  • [2] Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology?
    Marquet, P
    [J]. THERAPEUTIC DRUG MONITORING, 2002, 24 (01) : 125 - 133
  • [3] Optimizing LC-MS and LC-MS-MS Methods
    不详
    [J]. LC GC EUROPE, 2014, 27 (01) : 50 - 50
  • [4] Optimizing LC-MS and LC-MS-MS Methods
    不详
    [J]. LC GC NORTH AMERICA, 2014, 32 (01) : 74 - 74
  • [5] Development of LC-MS and LC-MS/MS Methods for Free Asparagine in Grains
    Chikasou, Masato
    Inohana, Syuichi
    Yokozeki, Toshiaki
    Tuchiya, Hitoshi
    Fujita, Kazuhiro
    [J]. FOOD HYGIENE AND SAFETY SCIENCE, 2018, 59 (05): : 248 - 256
  • [6] The application of LC-MS in forensic toxicology
    Dussy, FE
    Stäubli, CH
    Briellmann, TA
    [J]. CHIMIA, 2002, 56 (03) : 53 - 58
  • [7] LC-MS/MS in clinical chemistry
    Vogeser, Michael
    Seger, Christoph
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 883 : 1 - 2
  • [8] LC-MS/MS in clinical laboratories
    Kushnir, Mark M.
    Rockwood, Alan L.
    Bergquist, Jonas
    [J]. BIOANALYSIS, 2013, 5 (01) : 5 - 6
  • [9] Toxicology screening: Transitioning from a BioRad REMEDi instrument to an LC-MS/MS instrument for general toxicology screening of urine samples
    Walsh, Warren
    Banka, Tibor
    Verjee, Zulfikarali
    [J]. THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 491 - 491
  • [10] LC-MS/MS progress in newborn screening
    Lehotay, D. C.
    Hall, P.
    Lepage, J.
    Eichhorst, J. C.
    Etter, M. L.
    Greenberg, C. R.
    [J]. CLINICAL BIOCHEMISTRY, 2011, 44 (01) : 21 - 31